Determination of adenosine effects and adenosine receptors in murine corpus cavernosum

Journal of Pharmacology and Experimental Therapeutics

Volumn 322, Issue 2, 2007, Pages 678-685

  Tostes, Rita C ^a,b   Giachini, Fernanda R C ^a,b   Carneiro, Fernando S ^a,b   Leite, Romulo ^b   Inscho, Edward W ^b   Webb, R Clinton ^b  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 ANILINOADENOSINE; 2 CHLOROADENOSINE; 5 AMINO 2 (2 FURYL) 7 (2 PHENYLETHYL)PYRAZOLO[4,3 E][1,2,4]TRIAZOLO[1,5 C]PYRIMIDINE; 5' IODOTUBERCIDIN; 6 N CYCLOPENTYLADENOSINE; 8 CYCLOPENTYL 1,3 DIPROPYLXANTHINE; 9 (2 HYDROXY 3 NONYL)ADENINE; ADENOSINE KINASE INHIBITOR; ADENOSINE RECEPTOR; ADENOSINE RECEPTOR BLOCKING AGENT; DIPYRIDAMOLE; MRS 1706; N (4 ACETYLPHENYL) 2 [4 (2,3,6,7 TETRAHYDRO 2,6 DIOXO 1,3 DIPROPYL 1H PURIN 8 YL)PHENOXY]ACETAMIDE; PHENYLEPHRINE; UNCLASSIFIED DRUG;

ADRENERGIC NERVE; ADRENERGIC TRANSMISSION; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS CAVERNOSUM; DRUG DETERMINATION; DRUG INHIBITION; ELECTRIC FIELD; MALE; MOUSE; MUSCLE FIBER CONTRACTION; NONHUMAN; PENIS ERECTION; PRIORITY JOURNAL; SMOOTH MUSCLE FIBER; SYMPATHETIC NERVE;

2-CHLOROADENOSINE; ADENOSINE; ADRENERGIC ALPHA-ANTAGONISTS; ANIMALS; ATROPINE; BRETYLIUM TOSYLATE; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTRIC STIMULATION; ENZYME INHIBITORS; MALE; MICE; MICE, INBRED C57BL; MUSCLE CONTRACTION; MUSCLE RELAXATION; MUSCLE, SMOOTH; NG-NITROARGININE METHYL ESTER; PENILE ERECTION; PHENYLEPHRINE; PRAZOSIN; PURINES; PYRIMIDINES; RECEPTOR, ADENOSINE A2A; RECEPTOR, ADENOSINE A2B; RECEPTORS, PURINERGIC P1; TRIAZOLES;

EID: 34547119292     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.107.122705     Document Type: Article

References (39)

1. Andersson KE (2001) Pharmacology of penile erection. Pharmacol Rev 53:417-450.
2. Bruns RF, Fergus JH, Badger EW, Bristol JA, Santay LA, Hartman JD, Hays SJ, and Huang CC (1987) Binding of the A1-selective adenosine antagonist 8-cyclopentyl-1,3-dipropylxanthine to rat brain membranes. Naunyn Schmiedebergs Arch Pharmacol 335:59-63.
3. Burnstock G (2006) Historical review: ATP as a neurotransmitter. Trends Pharmacol Sci 27:166-176.
4. Chiang PH, Wu SN, Tsai EM, Wu CC, Shen MR, Huang CH, and Chiang CP (1994) Adenosine modulation of neurotransmission in penile erection. Br J Clin Pharmacol 38:357-362.
5. Davies LP, Baird-Lambert J, and Marwood JF (1986) Studies on several pyrrolo[2,3-d]pyrimidine analogues of adenosine which lack significant agonist activity at A1 and A2 receptors but have potent pharmacological activity in vivo. Biochem Pharmacol 35:3021-3029.
6. De Mey J, Burnstock G, and Vanhoutte PM (1979) Modulation of the evoked release of noradrenaline in canine saphenous vein via presynaptic receptors for adenosine but not ATP. Eur J Pharmacol 55:401-405.
7. Duarte-Araújo M, Nascimento C, Alexandrina Timoteo M, Magalhaes-Cardoso T, and Correia-de-Sa P (2004) Dual effects of adenosine on acetylcholine release from myenteric motoneurons are mediated by junctional facilitatory A(2A) and extra-junctional inhibitory A(1) receptors. Br J Pharmacol 141:925-934.
8. Dubey RK, Gillespie DG, Mi Z, Suzuki F, and Jackson EK (1996) Smooth muscle cell-derived adenosine inhibits cell growth. Hypertension 27:766-773.
9. Filippi S, Amerini S, Maggi M, Natali A, and Ledda F (1999) Studies on the mechanisms involved in the ATP-induced relaxation in human and rabbit corpus cavernosum. J Urol 161:326-331.
10. Filippi S, Mancini M, Amerini S, Bartolini M, Natali A, Mancina R, Forti G, Ledda F, and Maggi M (2000) Functional adenosine receptors in human corpora cavernosa. Int J Androl 23:210-217.
11. Fredholm BB, IJzerman AP, Jacobson KA, Klotz KN, and Linden J (2001) International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors. Pharmacol Rev 53:527-552.
12. Giuliano F and Rampin O (2004) Neural control of erection. Physiol Behav 83:189-201.
13. Grimm M, Kurz T, Schwarz M, Richardt D, Schafer U, Katus HA, and Richardt G (2001) Presynaptic regulation of cardiac norepinephrine release in ischemia. J Cardiovasc Pharmacol 38:58-68.
14. Illes P, Jackisch R, and Regenold JT (1988) Presynaptic P1-purinoceptors in jejunal branches of the rabbit mesenteric artery and their possible function. J Physiol 397:13-29.
15. Jacobson KA and Gao ZG (2006) Adenosine receptors as therapeutic targets. Nat Rev Drug Discov 5:247-264.
16. King AE, Ackley MA, Cass CE, Young JD, and Baldwin SA (2006) Nucleoside transporters: from scavengers to novel therapeutic targets. Trends Pharmacol Sci 27:416-425.
17. Kiss A, Farah K, Kim J, Garriock RJ, Drysdale TA, and Hammond JR (2000) Molecular cloning and functional characterization of inhibitor-sensitive (mENT1) and inhibitor-resistant (mENT2) equilibrative nucleoside transporters from mouse brain. Biochem J 352:363-372.
18. Klabunde RE (1983) Effects of dipyridamole on postischemic vasodilation and extracellular adenosine. Am J Physiol 244:H273-H280.
19. 3H]CCPA) - a high affinity agonist radioligand for A1 adenosine receptors. Naunyn Schmiedebergs Arch Pharmacol 340:679-683.
20. Leite R, Giachini FRC, Carneiro FS, Nunes KP, Tostes RC, and Webb RC (2007) Targets for the treatment of erectile dysfunction: is NO/cGMP still the answer? Recent Pat Cardiovas Drug Discov 2:119-132.
21. Lundberg JM (1996) Pharmacology of cotransmission in the autonomic nervous system: integrative aspects on amines, neuropeptides, adenosine triphosphate, amino acids and nitric oxide. Pharmacol Rev 48:113-178.
22. Mantelli L, Amerini S, Ledda F, Forti G, and Maggi M (1995) The potent relaxant effect of adenosine in rabbit corpora cavernosa is nitric oxide independent and mediated by A2 receptors. J Androl 16:312-317.
23. Minelli A, Bellezza I, Agostini M, Bracarda S, and Culig Z (2006) Mechanism of 2-chloroadenosine toxicity to PC3 cell line. Prostate 66:1425-1436.
24. Muller MJ and Paton DM (1979) Presynaptic inhibitory actions of 2-substituted adenosine derivatives on neurotransmission in rat vas deferens: effects of inhibitors of adenosine uptake and deamination. Naunyn Schmiedebergs Arch Pharmacol 306:23-28.
25. Noto T, Inoue H, Mochida H, and Kikkawa K (2001) Role of adenosine and P2 receptors in the penile tumescence in anesthetized dogs. Eur J Pharmacol 425:51-55.
26. Queiroz G, Talaia C, and Goncalves J (2003) Adenosine A2A receptor-mediated facilitation of noradrenaline release involves protein kinase C activation and attenuation of presynaptic inhibitory receptor-mediated effects in the rat vas deferens. J Neurochem 85:740-748.
27. Rongen GA, Lenders JW, Lambrou J, Willemsen JJ, Van Belle H, Thien T, and Smits P (1996) Presynaptic inhibition of norepinephrine release from sympathetic nerve endings by endogenous adenosine. Hypertension 27:933-938.
28. Shalev M, Staerman F, Allain H, Lobel B, and Saiag B (1999) Stimulation of P2Y purinoceptors induces, via nitric oxide production, endothelium-dependent relaxation of human isolated corpus cavernosum. J Urol 161:955-959.
29. Stolk M, Cooper E, Vilk G, Litchfield DW, and Hammond JR (2005) Subtype-specific regulation of equilibrative nucleoside transporters by protein kinase CK2. Biochem J 386:281-289.
30. Takahashi Y, Ishii N, Lue TF, and Tanagho EA (1991) Pharmacological effects of adenosine on canine penile erection. Tohoku J Exp Med 165:49-58.
31. Takahashi Y, Ishii N, Lue TF, and Tanagho EA (1992) Effects of adenosine on canine penile erection. J Urol 148:1323-1325.
32. Taylor DA and Williams M (1982) Interaction of 2-phenylaminoadenosine (CV 1808) with adenosine systems in rat tissues. Eur J Pharmacol 85:335-338.
33. Teixeira CE, Ying Z, and Webb RC (2005) Proerectile effects of the Rho-kinase inhibitor (S)-(+)-2-methyl-1-[(4-methyl-5-isoquinolinyl) sulfonyl]homopiperazine (H-1152) in the rat penis. J Pharmacol Exp Ther 315:155-162.
34. Tong YC, Broderick G, Hypolite J, and Levin RM (1992) Correlations of purinergic, cholinergic and adrenergic functions in rabbit corporal cavernosal tissue. Pharmacology 45:241-249.
35. Ullman B, Cohen A, and Martin DW (1976) Characterization of a cell culture model for the study of adenosine deaminase- and purine nucleoside phosphorylase-deficient immunologic disease. Cell 9:205-211.
36. 3H]-noradrenaline release in rabbit brain cortex slices by direct action at presynaptic adenosine A1-receptors. Naunyn Schmiedebergs Arch Pharmacol 346:187-196.
37. Wu HY, Broderick GA, Suh JK, Hypolite JA, and Levin RM (1993) Effects of purines on rabbit corpus cavernosum contractile activity. Int J Impot Res 5:161-167.
38. Wykretowicz A, Filipiak A, Szczepanik A, and Wysocki H (2004) Dipyridamole inhibits hydroxylamine augmented nitric oxide (NO) production by activated polymorphonuclear neutrophils through an adenosine-independent mechanism. Physiol Res 53:645-652.
39. Zimmermann H (2000) Extracellular metabolism of ATP and other nucleotides. Naunyn Schmiedebergs Arch Pharmacol 362:299-309.